Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

Osivax

Vaccines

Vaccines Weekly Update - September 19th 2025

Vaccine Research Update: PCV21 in Children, COVID-19 for Immunocompromised,…

Vaccines

Vaccines Weekly Update - July 11th 2025

🔬💉 Vaccines Global Breakthroughs: Flu, Malaria, Cancer, COVID-19 and more In…

Vaccines

Vaccines Weekly Update - June 13th 2025

Chikungunya, RSV, Universal Dengue, Flu-COVID Combo & More | June 2025…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Zetagen $12.9 million Series B1 in breast cancer
Lucid Diligence Brief: Imugene onCARlytics Carteyva collaboration
Respiratory Video Recap—November 28, 2025
Vaccines Video Recap—November 28, 2025
Public Health Today—28 November, 2025

Tags

AAT deficiency Abbott Abeona Therapeutics ACTH-dependent Cushing’s Adrenal disorders AERA-109 Allergic fungal rhinosinusitis Appili Therapeutics biomarker discovery Biomea BTN3A Cardiac arrhythmias chronic myocardial ischemia CRO digital obesity care DNA screening Drug discovery AI Efpeglenatide Ensem Therapeutics ERβ ligands European Commission GPX4 HEOR intranasal therapeutics iPSC Itvisma LCA5 Lexeo Therapeutics MALE march biosciences MedinCell methotrexate Myelodysplastic syndromes Nira Medical One Medical Organoids Pascal personalized vaccines Pier 88 Health Qilu Pharmaceutical Rein Therapeutics respiratory medicine Sentynl Shingrix sk biopharmaceuticals

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Zetagen $12.9 million Series B1 in breast cancer
Lucid Diligence Brief: Imugene onCARlytics Carteyva collaboration
Respiratory Video Recap—November 28, 2025
Vaccines Video Recap—November 28, 2025
Public Health Today—28 November, 2025

TAGS

AAT deficiency Abbott Abeona Therapeutics ACTH-dependent Cushing’s Adrenal disorders AERA-109 Allergic fungal rhinosinusitis Appili Therapeutics biomarker discovery Biomea BTN3A Cardiac arrhythmias chronic myocardial ischemia CRO digital obesity care DNA screening Drug discovery AI Efpeglenatide Ensem Therapeutics ERβ ligands European Commission GPX4 HEOR intranasal therapeutics iPSC Itvisma LCA5 Lexeo Therapeutics MALE march biosciences MedinCell methotrexate Myelodysplastic syndromes Nira Medical One Medical Organoids Pascal personalized vaccines Pier 88 Health Qilu Pharmaceutical Rein Therapeutics respiratory medicine Sentynl Shingrix sk biopharmaceuticals

Consulting Services
For Investors
- Lucid Diligence Briefs
- Venture Capital
Case Studies
Insights
- Conference Previews
- Conference Social Media Reports
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy